Stig is a professional board member and investor. He has 40 years of management experience, mainly from H. Lundbeck A/S where he held a number of positions in Denmark and abroad.
From 2003 until 2011, Stig was member of the executive board and responsible for Lundbeck’s commercial operations including establishment of partnership alliances as well as global roll-out of subsidiaries and other sales activities.
In the last 15 years Stig has been an active investor and chairman / board member, primarily in pharmaceutical and diagnostics companies in Europe and in America.
Stig is a professional board member and investor. He has 40 years of management experience, mainly from H. Lundbeck A/S where he held a number of positions in Denmark and abroad.
From 2003 until 2011, Stig was member of the executive board and responsible for Lundbeck’s commercial operations including establishment of partnership alliances as well as global roll-out of subsidiaries and other sales activities.
In the last 15 years Stig has been an active investor and chairman / board member, primarily in pharmaceutical and diagnostics companies in Europe and in America.
Here goes your text … Select any part of your text to access the formatting toolbar.
Here goes your text … Select any part of your text to access the formatting toolbar.
Stig is a professional board member and investor. He has 40 years of management experience, mainly from H. Lundbeck A/S where he held a number of positions in Denmark and abroad.
From 2003 until 2011, Stig was member of the executive board and responsible for Lundbeck’s commercial operations including establishment of partnership alliances as well as global roll-out of subsidiaries and other sales activities.
In the last 15 years Stig has been an active investor and chairman / board member, primarily in pharmaceutical and diagnostics companies in Europe and in America.
Stig is a professional board member and investor. He has 40 years of management experience, mainly from H. Lundbeck A/S where he held a number of positions in Denmark and abroad.
From 2003 until 2011, Stig was member of the executive board and responsible for Lundbeck’s commercial operations including establishment of partnership alliances as well as global roll-out of subsidiaries and other sales activities.
In the last 15 years Stig has been an active investor and chairman / board member, primarily in pharmaceutical and diagnostics companies in Europe and in America.